$3.81 Billion is the total value of Perceptive Advisors's 127 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 42.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $463,226,000 | +17.3% | 4,715,250 | -1.0% | 12.14% | +9.8% |
| FOLD | AMICUS THERAPEUTICS INC | $312,782,000 | +3.9% | 20,024,424 | 0.0% | 8.20% | -2.8% | |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $218,266,000 | -9.4% | 4,828,910 | -3.2% | 5.72% | -15.2% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $181,902,000 | +19.2% | 1,846,911 | +44.2% | 4.77% | +11.6% |
| ZGNX | ZOGENIX INC | $175,489,000 | +10.4% | 3,970,357 | 0.0% | 4.60% | +3.3% | |
| SOLID BIOSCIENCES INC | $139,927,000 | +375.1% | 3,927,222 | 0.0% | 3.67% | +344.6% | ||
| LJPC | LA JOLLA PHARMACEUTICAL CO | $125,828,000 | -2.0% | 4,313,611 | 0.0% | 3.30% | -8.3% | |
| BHVN | Sell | BIOHAVEN PHARMACEUTICAL HOLDING CO L | $108,429,000 | +52.2% | 2,743,647 | -6.3% | 2.84% | +42.5% |
| DOVA | Buy | DOVA PHARMACEUTICALS INC | $93,525,000 | +24.0% | 3,125,851 | +12.4% | 2.45% | +16.1% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $74,908,000 | -28.1% | 5,852,202 | -5.0% | 1.96% | -32.7% |
| XLRN | Buy | ACCELERON PHARMA INC | $74,149,000 | +25.1% | 1,528,205 | +0.8% | 1.94% | +17.0% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $71,352,000 | +11.0% | 1,072,647 | +9.2% | 1.87% | +3.9% |
| VRCA | New | VERRICA PHARMACEUTICALS INC | $67,287,000 | – | 3,410,412 | +100.0% | 1.76% | – |
| RGNX | Sell | REGENXBIO INC | $62,215,000 | +136.5% | 867,106 | -1.6% | 1.63% | +121.3% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $61,014,000 | -35.4% | 961,147 | -6.7% | 1.60% | -39.6% |
| ALBO | ALBIREO PHARMA INC | $60,504,000 | +9.0% | 1,704,330 | 0.0% | 1.59% | +2.0% | |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $57,537,000 | -40.9% | 463,450 | -46.9% | 1.51% | -44.7% |
| RTRX | RETROPHIN INC | $57,387,000 | -20.1% | 3,212,871 | 0.0% | 1.50% | -25.2% | |
| MMSI | Buy | MERIT MED SYS INC | $55,399,000 | +16.9% | 1,082,013 | +3.5% | 1.45% | +9.4% |
| QURE | Buy | UNIQURE NV | $54,607,000 | +66.6% | 1,444,628 | +3.6% | 1.43% | +56.0% |
| MYOK | Buy | MYOKARDIA INC | $54,078,000 | +32.8% | 1,089,169 | +30.5% | 1.42% | +24.3% |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $53,900,000 | – | 4,703,398 | +100.0% | 1.41% | – |
| KDMN | Buy | KADMON HLDGS INC | $52,531,000 | +139.3% | 13,165,746 | +154.9% | 1.38% | +123.9% |
| QTNT | Buy | QUOTIENT LTD | $52,058,000 | +83.2% | 6,483,020 | +7.5% | 1.36% | +71.5% |
| CORI | CORIUM INTERNATIONAL INC | $50,921,000 | -30.2% | 6,357,133 | 0.0% | 1.34% | -34.6% | |
| ISRG | Buy | INTUITIVE SURGICAL INC | $47,848,000 | +1059.1% | 100,000 | +900.0% | 1.25% | +981.0% |
| HUM | Buy | HUMANA INC | $44,114,000 | +170.3% | 148,218 | +144.1% | 1.16% | +153.2% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $43,930,000 | -30.1% | 1,921,715 | -13.0% | 1.15% | -34.5% |
| ARGX | Sell | ARGENX SE ADRadr | $43,879,000 | +1.5% | 529,560 | -1.5% | 1.15% | -5.0% |
| DBVT | Buy | DBV TECHNOLOGIES SA SHS SPONSORED AMERICAN DEPOSITadr | $40,667,000 | -15.8% | 2,108,198 | +0.7% | 1.07% | -21.2% |
| XNCR | Sell | XENCOR INC | $39,530,000 | +0.0% | 1,068,095 | -19.0% | 1.04% | -6.4% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $36,808,000 | +9.1% | 2,742,821 | -2.1% | 0.96% | +2.1% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $36,710,000 | +440.4% | 841,978 | +389.6% | 0.96% | +406.3% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $35,160,000 | +3837.3% | 713,191 | +2351.6% | 0.92% | +3588.0% |
| ADMA | Buy | ADMA BIOLOGICS INC | $29,410,000 | +67.3% | 6,521,102 | +70.7% | 0.77% | +56.7% |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $28,004,000 | +86.0% | 1,084,159 | +72.1% | 0.73% | +73.9% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $27,667,000 | -8.1% | 564,579 | +27.7% | 0.72% | -14.0% |
| VBIV | VBI VACCINES INC | $26,581,000 | -21.4% | 9,665,843 | 0.0% | 0.70% | -26.5% | |
| ECYT | Sell | ENDOCYTE INC | $26,519,000 | +32.5% | 1,921,700 | -12.7% | 0.70% | +23.9% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $25,234,000 | +11.0% | 660,406 | -12.7% | 0.66% | +4.1% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $25,029,000 | +112.4% | 800,686 | +35.2% | 0.66% | +98.8% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $24,989,000 | -5.4% | 308,006 | -26.6% | 0.66% | -11.5% |
| ALDX | ALDEYRA THERAPEUTICS INC | $24,529,000 | +6.0% | 3,085,458 | 0.0% | 0.64% | -0.8% | |
| ATHN | New | ATHENAHEALTH INC | $23,871,000 | – | 150,000 | +100.0% | 0.63% | – |
| GTXI | New | GTX INC DEL | $22,988,000 | – | 1,501,501 | +100.0% | 0.60% | – |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $22,110,000 | -5.8% | 2,215,400 | -10.0% | 0.58% | -11.7% |
| NEPT | NEPTUNE TECHNOLOGIES AND BIORESO | $20,379,000 | -15.4% | 8,574,015 | 0.0% | 0.53% | -20.9% | |
| MOTS | MOTUS GI HLDGS INC | $20,207,000 | +60.5% | 2,810,542 | 0.0% | 0.53% | +50.1% | |
| ZYME | Buy | ZYMEWORKS INC | $15,920,000 | +104.7% | 1,123,890 | +62.0% | 0.42% | +91.3% |
| ABMD | Sell | ABIOMED INC | $14,990,000 | -84.5% | 36,646 | -89.0% | 0.39% | -85.5% |
| NVTA | Buy | INVITAE CORP | $14,855,000 | +70.7% | 2,021,100 | +9.2% | 0.39% | +59.4% |
| EIDX | New | EIDOS THERAPEUTICS INC | $13,971,000 | – | 686,922 | +100.0% | 0.37% | – |
| GLPG | Sell | GALAPAGOS NVspon adr | $13,908,000 | -32.4% | 150,875 | -26.9% | 0.36% | -36.6% |
| SRRA | Sell | SIERRA ONCOLOGY INC | $13,320,000 | +28.7% | 4,500,000 | -10.0% | 0.35% | +20.3% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $12,900,000 | -47.9% | 75,898 | -50.0% | 0.34% | -51.2% |
| ABEOW | ABEONA THERAPEUTICS INCw exp 12/24/201 | $12,810,000 | +7.1% | 1,259,636 | 0.0% | 0.34% | +0.3% | |
| TDOC | Sell | TELADOC INC | $11,320,000 | -46.0% | 195,000 | -62.5% | 0.30% | -49.4% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $10,817,000 | -41.7% | 282,798 | -38.9% | 0.28% | -45.4% |
| MNLO | Sell | MENLO THERAPEUTICS INC | $10,079,000 | -83.2% | 1,241,287 | -22.4% | 0.26% | -84.3% |
| SYBX | SYNLOGIC INC | $9,268,000 | +4.8% | 942,852 | 0.0% | 0.24% | -2.0% | |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $9,010,000 | -45.9% | 32,213 | -77.4% | 0.24% | -49.4% |
| XERS | New | XERIS PHARMACEUTICALS INC | $8,541,000 | – | 450,000 | +100.0% | 0.22% | – |
| ANI PHARMACEUTICALS INCnote 3.005 12/0 | $8,458,000 | +3.0% | 7,500,000 | 0.0% | 0.22% | -3.5% | ||
| AXGN | New | AXOGEN INC | $8,291,000 | – | 165,000 | +100.0% | 0.22% | – |
| FLXN | FLEXION THERAPEUTICS INC | $7,962,000 | +15.4% | 307,989 | 0.0% | 0.21% | +8.3% | |
| CLSD | Sell | CLEARSIDE BIOMEDICAL INC | $7,599,000 | -1.1% | 707,581 | -1.1% | 0.20% | -7.4% |
| MRNS | MARINUS PHARMACEUTICALS INC | $6,417,000 | +85.1% | 907,732 | 0.0% | 0.17% | +73.2% | |
| TBIO | New | TRANSLATE BIO INC | $6,325,000 | – | 500,000 | +100.0% | 0.17% | – |
| OMED | ONCOMED PHARMACEUTICALS | $6,054,000 | -27.4% | 2,620,897 | 0.0% | 0.16% | -31.8% | |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $5,909,000 | -74.8% | 150,695 | -68.4% | 0.16% | -76.4% |
| CDNA | Sell | CAREDX INC | $5,724,000 | -31.0% | 467,676 | -55.1% | 0.15% | -35.3% |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $5,598,000 | -2.3% | 1,117,324 | 0.0% | 0.15% | -8.7% | |
| HSGX | HISTOGENICS CORP | $5,508,000 | -9.1% | 2,203,277 | 0.0% | 0.14% | -15.3% | |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $4,970,000 | +88.6% | 365,445 | 0.0% | 0.13% | +75.7% | |
| TSRO | New | TESARO INC | $4,447,000 | – | 100,000 | +100.0% | 0.12% | – |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $4,274,000 | -40.0% | 1,891,192 | -23.1% | 0.11% | -44.0% |
| MTEM | MOLECULAR TEMPLATES INC | $3,787,000 | -34.6% | 724,133 | 0.0% | 0.10% | -38.9% | |
| IVC | INVACARE CORP | $3,720,000 | +6.9% | 200,000 | 0.0% | 0.10% | +1.0% | |
| ATNX | ATHENEX INC | $3,545,000 | +9.7% | 190,000 | 0.0% | 0.09% | +2.2% | |
| STIM | New | NEURONETICS INC | $3,340,000 | – | 125,500 | +100.0% | 0.09% | – |
| ODT | ODONATE THERAPEUTICS INC | $3,312,000 | +4.2% | 150,000 | 0.0% | 0.09% | -2.2% | |
| NVTRQ | Sell | NUVECTRA CORP | $3,274,000 | -34.6% | 159,466 | -58.5% | 0.09% | -38.6% |
| ALNA | ALLENA PHARMACEUTICALS INC | $3,258,000 | +18.3% | 250,000 | 0.0% | 0.08% | +10.4% | |
| GERN | New | GERON CORP | $2,922,000 | – | 2,550,000 | +100.0% | 0.08% | – |
| ACHN | ACHILLION PHARMACEUTICALS INC | $2,830,000 | -23.7% | 1,000,000 | 0.0% | 0.07% | -28.8% | |
| New | CHAMPIONS ONCOLOGY INC | $2,326,000 | – | 366,972 | +100.0% | 0.06% | – | |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $1,928,000 | – | 111,111 | +100.0% | 0.05% | – |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,923,000 | +23.8% | 157,679 | 0.0% | 0.05% | +16.3% | |
| AGRX | AGILE THERAPEUTICS INC | $1,744,000 | -80.8% | 3,530,000 | 0.0% | 0.05% | -81.9% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $1,650,000 | -32.2% | 275,000 | 0.0% | 0.04% | -36.8% | |
| EVH | New | EVOLENT HEALTH INCcl a | $1,474,000 | – | 70,000 | +100.0% | 0.04% | – |
| VICL | VICAL INC | $1,314,000 | -20.7% | 1,142,858 | 0.0% | 0.03% | -26.1% | |
| FCAU | FIAT CHRYSLER AUTOMOBILES N. | $1,171,000 | -7.9% | 62,000 | 0.0% | 0.03% | -13.9% | |
| CSU | CAPITAL SR LIVING CORP | $1,069,000 | -0.7% | 100,173 | 0.0% | 0.03% | -6.7% | |
| TRHC | TABULA RASA HEALTHCARE INC | $936,000 | +64.5% | 14,663 | 0.0% | 0.02% | +56.2% | |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $954,000 | -93.3% | 59,662 | -94.0% | 0.02% | -93.7% |
| BGNE | BEIGENE LTDsponsored adr | $876,000 | -8.6% | 5,700 | 0.0% | 0.02% | -14.8% | |
| ALQA | ALLIQUA BIOMEDICAL INC | $867,000 | +5.6% | 423,394 | 0.0% | 0.02% | 0.0% | |
| RACE | FERRARI N.V. | $837,000 | +12.0% | 6,200 | 0.0% | 0.02% | +4.8% | |
| PRTO | PROTEON THERAPEUTICS INC | $819,000 | -1.9% | 334,116 | 0.0% | 0.02% | -8.7% | |
| AZRX | AZURRX BIOPHARMA INC | $730,000 | +2.2% | 227,272 | 0.0% | 0.02% | -5.0% | |
| ARRY | ARRAY BIOPHARMA INC | $673,000 | +2.7% | 40,133 | 0.0% | 0.02% | 0.0% | |
| PTCT | Sell | PTC THERAPEUTICS INC | $653,000 | -92.0% | 19,367 | -93.5% | 0.02% | -92.5% |
| LOXO | New | LOXO ONCOLOGY INC | $653,000 | – | 3,765 | +100.0% | 0.02% | – |
| GTHX | New | G1 THERAPEUTICS INC | $611,000 | – | 14,055 | +100.0% | 0.02% | – |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $577,000 | – | 24,213 | +100.0% | 0.02% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $585,000 | – | 49,302 | +100.0% | 0.02% | – |
| VRAY | Sell | VIEWRAY INC | $519,000 | -19.3% | 75,000 | -25.0% | 0.01% | -22.2% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $501,000 | – | 24,489 | +100.0% | 0.01% | – |
| SENS | SENSEONICS HLDGS INC | $473,000 | +37.1% | 115,000 | 0.0% | 0.01% | +20.0% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $428,000 | -8.7% | 80,845 | 0.0% | 0.01% | -15.4% | |
| PERNIX THERAPEUTICS HLDGS INdbvc 4.250% 4/0 | $426,000 | -7.8% | 1,000,000 | 0.0% | 0.01% | -15.4% | ||
| VTL | New | VITAL THERAPIES INC | $405,000 | – | 150,000 | +100.0% | 0.01% | – |
| CASI | CASI PHARMACEUTICALS INC | $360,000 | +97.8% | 43,682 | 0.0% | 0.01% | +80.0% | |
| SGMO | SANGAMO THERAPEUTICS INC | $355,000 | -25.3% | 25,000 | 0.0% | 0.01% | -30.8% | |
| NKTR | NEKTAR THERAPEUTICS | $296,000 | -54.0% | 6,057 | 0.0% | 0.01% | -55.6% | |
| VRNA | Sell | VERONA PHARMA PLCsponsored adr | $307,000 | -72.7% | 22,327 | -60.2% | 0.01% | -74.2% |
| HCM | HUTCHISON CHINA MEDITECH LTDsponsored adr | $301,000 | +1.7% | 10,000 | 0.0% | 0.01% | 0.0% | |
| VCEL | VERICEL CORP | $264,000 | -2.6% | 27,211 | 0.0% | 0.01% | -12.5% | |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $272,000 | – | 25,694 | +100.0% | 0.01% | – |
| TGTX | New | TG THERAPEUTICS INC | $258,000 | – | 100,000 | +100.0% | 0.01% | – |
| ACST | Buy | ACASTI PHARMA INCcl a new | $117,000 | -38.4% | 206,677 | +10.8% | 0.00% | -40.0% |
| ONCS | ONCOSEC MED INC | $69,000 | -26.6% | 50,000 | 0.0% | 0.00% | -33.3% | |
| ELOX | New | ELLOX PHARMACEUTICALS INC | $50,000 | – | 2,961 | +100.0% | 0.00% | – |
| CAPR | CAPRICOR THERAPEUTICS INC | $5,000 | 0.0% | 4,000 | 0.0% | 0.00% | – | |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -50,000 | -100.0% | 0.00% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -0.00% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS DEL | $0 | – | -100,000 | -100.0% | -0.01% | – |
| REGN | Exit | REGENERON PHARMACEUTICALScall | $0 | – | -50,000 | -100.0% | -0.01% | – |
| VTL | Exit | VITAL THERAPIES INCput | $0 | – | -150,000 | -100.0% | -0.01% | – |
| GERN | Exit | GERON CORPput | $0 | – | -600,000 | -100.0% | -0.02% | – |
| CUTR | Exit | CUTERA INC | $0 | – | -11,981 | -100.0% | -0.02% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -9,132 | -100.0% | -0.02% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -10,769 | -100.0% | -0.02% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -55,713 | -100.0% | -0.03% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -162,500 | -100.0% | -0.03% | – |
| VIVE | Exit | VIVEVE MED INC | $0 | – | -334,894 | -100.0% | -0.03% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -400,000 | -100.0% | -0.04% | – |
| CSBR | Exit | CHAMPIONS ONCOLOGY INC | $0 | – | -366,973 | -100.0% | -0.04% | – |
| CBIO | Exit | CATALYST BIOSCIENCES IINC | $0 | – | -55,000 | -100.0% | -0.04% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -70,000 | -100.0% | -0.04% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -900,000 | -100.0% | -0.04% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INCcall | $0 | – | -200,000 | -100.0% | -0.04% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -15,000 | -100.0% | -0.06% | – |
| INCY | Exit | INCYTE CORPput | $0 | – | -100,000 | -100.0% | -0.06% | – |
| AKCA | Exit | AKCEA THERAPEUTICS INC | $0 | – | -97,144 | -100.0% | -0.07% | – |
| ADXS | Exit | ADVAXIS INC | $0 | – | -1,500,000 | -100.0% | -0.07% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -20,000 | -100.0% | -0.15% | – |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -593,750 | -100.0% | -0.17% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -275,000 | -100.0% | -0.17% | – |
| INCY | Exit | INCYTE CORPcall | $0 | – | -1,510,000 | -100.0% | -0.20% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -300,000 | -100.0% | -0.26% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -1,295,841 | -100.0% | -0.26% | – |
| TFX | Exit | TELEFLEX INC | $0 | – | -40,900 | -100.0% | -0.29% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -440,000 | -100.0% | -0.40% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -618,957 | -100.0% | -0.53% | – |
| ABLX | Exit | ABLYNX NVsponsored adr | $0 | – | -370,000 | -100.0% | -0.56% | – |
| AGIO | Exit | AGIO PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.57% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -237,281 | -100.0% | -0.69% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -276,400 | -100.0% | -0.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-11-01
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.